CardioSource WorldNews | Page 39

Proven protection from
Sudden Cardiac Death
+ so much more
The LifeVest® provides
proven protection from
Sudden Cardiac Death with a
connection to your patients’
changing cardiac condition
through the LifeVest Network.

1 in 14 patients

With the LifeVest Network, you can
diagnose arrhythmic events including:

require arrhythmia
intervention while
wearing the LifeVest.

1

+
+
+
+

Sustained VT
Non-sustained VT
Atrial arrhythmias/SVT
Severe bradycardia/Asystole

Learn more at www.zoll.com/lifevestnetwork or
by contacting your LifeVest Representative today.
1. Kutyifa V, Goldenberg I, Zareba W, et al. Results from the prospective registry of patients using the wearable defibrillator
(WEARIT-II Registry). Presented as Late Breaking Clinical Trial at the 2014 European Society of Cardiology Congress, Sept 3, 2014.
© 2015 ZOLL Medical Corporation. ZOLL and LifeVest are registered trademarks of ZOLL Medical Corporation in the United
States and/or other countries.

20C0485 rev FI